Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
EJNMMI Physics|December 28, 2020
Accuracy and precision of zero-echo-time, single- and multi-atlas attenuation correction for dynamic [11C]PE2I PET-MR brain imagingJoão M Sousa, Lieuwe Appel, Inés Merida, et al.
BMC Medical Ethics|October 12, 2023
Patients accept therapy using embryonic stem cells for Parkinson's disease: a discrete choice experimentKarin Schölin Bywall, Jennifer Drevin, Catharina Groothuis-Oudshoorn, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 28, 2020
Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's DiseaseValter Niemela, Anne-Marie Landtblom, Dag Nyholm, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 22, 2020
A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease DementiaPer Svenningsson, Per Odin, Nil Dizdar, et al.
European Journal of Clinical Pharmacology|January 20, 2017
Levodopa/carbidopa microtablets in Parkinson's disease: a study of pharmacokinetics and blinded motor assessmentMarina Senek, Sten-Magnus Aquilonius, Håkan Askmark, et al.
Parkinsonism & Related Disorders|June 20, 2016
Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costsSven E Pålhagen, Olof Sydow, Anders Johansson, et al.
Computer Methods and Programs in Biomedicine|January 27, 2020
A multiple motion sensors index for motor state quantification in Parkinson's diseaseSomayeh Aghanavesi, Jerker Westin, Filip Bergquist, et al.
Brain : a Journal of Neurology|May 13, 2022
Phosphorylated α-synuclein in skin Schwann cells: a new biomarker for multiple system atrophyVincenzo Donadio, Alex Incensi, Giovanni Rizzo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 27, 2017
A randomized, double-blind, placebo-controlled trial of camicinal in Parkinson's diseaseSarah L Marrinan, Tal Otiker, Lakshmi S Vasist, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 17, 2025
NLX-112 Randomized Phase 2A Trial: Safety, Tolerability, Anti-Dyskinetic, and Anti-Parkinsonian EfficacyPer Svenningsson, Per Odin, Filip Bergquist, et al.
Pageof 11